SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q2 2022
Institutional positions in SAB Biotherapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +10 vs. Q1 2022
- Shares held
- 3.08M
- +1.29M (+72.3%) vs. Q1 2022
- Total value
- $4.45M
- −$2.27M (−33.8%) vs. Q1 2022
- New holders
- 13
- 9 more added
- Sold out
- 3
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 721,651 | $1.05M | 0.00% | +500+0.1% | Added |
| First PREMIER Bank | 652,440 | $946.0K | 0.28% | +652,440 | New |
| Geode Capital Management, LLC | 316,663 | $459.0K | 0.00% | +15,553+5.2% | Added |
| Meteora Capital, LLC | 292,538 | $424.0K | 0.08% | +292,538 | New |
| Shaolin Capital Management LLC | 275,000 | $399.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 127,446 | $185.0K | 0.00% | +54,928+75.7% | Added |
| Bridgeway Capital Management, LLC | 84,000 | $122.0K | 0.00% | +84,000 | New |
| State Street Corp | 81,241 | $118.0K | 0.00% | +38,900+91.9% | Added |
| Institutional & Family Asset Management, LLC | 78,115 | $113.0K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 64,220 | $93.0K | 0.00% | +64,220 | New |
| Creative Planning | 46,528 | $67.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 44,476 | $64.0K | 0.00% | 00.0% | Unchanged |
| Silver Oak Securities, Inc | 51,941 | $64.0K | 0.01% | +51,941 | New |
| Veritable, L.P. | 43,551 | $63.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 24,752 | $36.0K | 0.00% | −212−0.8% | Reduced |
| LGL Partners, LLC | 23,000 | $33.0K | 0.01% | +23,000 | New |
| AE Wealth Management LLC | 18,700 | $27.0K | 0.00% | +18,700 | New |
| Charles Schwab Investment Management Inc | 16,238 | $24.0K | 0.00% | +16,238 | New |
| Brookstone Capital Management | 19,618 | $24.0K | 0.00% | +19,618 | New |
| Goldman Sachs Group Inc | 14,462 | $21.0K | 0.00% | −1,032−6.7% | Reduced |
| ETF Managers Group, LLC | 13,581 | $19.0K | 0.00% | +394+3.0% | Added |
| Elgethun Capital Management | 13,296 | $18.0K | 0.01% | +13,296 | New |
| Kestra Advisory Services, LLC | 11,000 | $16.0K | 0.00% | +11,000 | New |
| 1st Source Bank | 10,000 | $15.0K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 8,176 | $12.0K | 0.00% | +6,445+372.3% | Added |
| Penserra Capital Management LLC | 6,405 | $9.00K | 0.00% | +2,681+72.0% | Added |
| Spectrum Management Group, LLC | 5,030 | $7.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4,820 | $7.00K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 3,926 | $5.00K | 0.00% | −2,500−38.9% | Reduced |
| JPMorgan Chase & Co | 1,808 | $3.00K | 0.00% | −3,192−63.8% | Reduced |
| Advisor Group Holdings, Inc. | 2,213 | $3.00K | 0.00% | +883+66.4% | Added |
| Citigroup Inc | 639 | $1.00K | 0.00% | −6,380−90.9% | Reduced |
| Bank of America Corp | 776 | $1.00K | 0.00% | −2,003−72.1% | Reduced |
| UBS Group AG | 1,000 | $1.00K | 0.00% | −407−28.9% | Reduced |
| Rockefeller Capital Management L.P. | 1,200 | $1.00K | 0.00% | +100+9.1% | Added |
| Daiwa Securities Group Inc. | 127 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 167 | $0 | 0.00% | +167 | New |
| Alps Advisors Inc | 0 | $0 | 0.00% | −45,083−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −24,179−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −250−100.0% | Sold out |